Related Experiment Video

Updated: Jun 21, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Alemtuzumab versus interferon beta-1a in early multiple sclerosis

Dennis Bourdette1, Vijayshree Yadav

  • 1MS Center of Oregon and the Department of Neurology of Oregon Health & Science University, Portland, OR 97239, USA. yadavv@ohsu.edu

Current Neurology and Neuroscience Reports
|August 12, 2009
PubMed
Summary

No abstract available in PubMed .

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...